NO20081220L - Nytt cercosporamidderivat - Google Patents

Nytt cercosporamidderivat

Info

Publication number
NO20081220L
NO20081220L NO20081220A NO20081220A NO20081220L NO 20081220 L NO20081220 L NO 20081220L NO 20081220 A NO20081220 A NO 20081220A NO 20081220 A NO20081220 A NO 20081220A NO 20081220 L NO20081220 L NO 20081220L
Authority
NO
Norway
Prior art keywords
group
alkyl group
halogenated
hydrogen atom
cercosporamide derivative
Prior art date
Application number
NO20081220A
Other languages
English (en)
Inventor
Akihiro Furukawa
Jun Ohsumi
Tsuyoshi Arita
Takehiro Fukuzaki
Kazushi Araki
Makoto Mori
Takayuki Momose
Takeshi Honda
Masanori Kuroha
Ryo Okuyama
Sasumu Satoh
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of NO20081220L publication Critical patent/NO20081220L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Oppfinnelsen vedrører et nytt cercosporamidderivat som har en god hypoglykemisk effekt og er anvendbart til et terapeutisk legemiddel og/eller profylaktisk legemiddel for sukkersyke, et farmakologisk akseptabelt salt derav eller en ester derav. Cercosporamid-derivatet har den generelle formel (I): hvor X er et oksygenatom eller lignende; R1 er et hydrogenatom eller en C1-C6-alkylgruppe; R2 er et hydrogenatom, en C1-C6-alkylgruppe eller en halogenert C1-C6-alkylgruppe; R3 er et hydrogenatom eller en C1-C6-alkylgruppe; R4 er en C6-C10-arylgruppe som kan være substituert med 1-5 grupper uavhengig valgt fra substituentgruppe (a) eller lignende; n er 1, 2 eller 3; og substituentgruppen (a) er et halogenatom, en C1-C6-alkylgruppe, en halogenert C1-C6-alkylgruppe, en C2-C6-alkenylgruppe, en C2-C6-alkynylgruppe, en C1-C6-alkoksy-gruppe, en halogenert C1-C6-alkoksy-gruppe, en C2_C6-alkenyloksygruppe, en C2-C6-alkynyloksygruppe og lignende.
NO20081220A 2005-08-09 2008-03-07 Nytt cercosporamidderivat NO20081220L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005230558 2005-08-09
JP2005379060 2005-12-28
PCT/JP2006/315621 WO2007018193A1 (ja) 2005-08-09 2006-08-08 新規セルコスポラミド誘導体

Publications (1)

Publication Number Publication Date
NO20081220L true NO20081220L (no) 2008-05-08

Family

ID=37727376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081220A NO20081220L (no) 2005-08-09 2008-03-07 Nytt cercosporamidderivat

Country Status (12)

Country Link
US (1) US20090036492A1 (no)
EP (1) EP1914229B1 (no)
JP (1) JP4085129B2 (no)
KR (1) KR20080033367A (no)
AU (1) AU2006277289A1 (no)
CA (1) CA2618622A1 (no)
DE (1) DE602006014973D1 (no)
IL (1) IL189172A0 (no)
NO (1) NO20081220L (no)
RU (1) RU2008108997A (no)
TW (1) TW200740786A (no)
WO (1) WO2007018193A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007018194A1 (ja) * 2005-08-09 2009-02-19 第一三共株式会社 セルコスポラミドの製造方法
WO2008096769A1 (ja) * 2007-02-08 2008-08-14 Daiichi Sankyo Company, Limited 置換されたセルコスポラミド誘導体を含有する医薬
PL216649B1 (pl) 2011-06-06 2014-04-30 Univ Warszawski Nowe kompleksy rutenu, sposób ich wytwarzania oraz zastosowanie w reakcji metatezy olefin
CN103755827B (zh) * 2014-01-16 2015-12-09 合肥工业大学 粒毛盘菌胞外多糖羧甲基化衍生物及其制抗肾衰药的用途
WO2016074696A1 (en) * 2014-11-10 2016-05-19 Givaudan Ag Perfume ingredients and perfume preparations containing same
JP2019510061A (ja) * 2016-03-31 2019-04-11 サウス オーストラリアン ヘルス アンド メディカル リサーチ インスティテュート リミテッドＳｏｕｔｈ Ａｕｓｔｒａｌｉａｎ Ｈｅａｌｔｈ Ａｎｄ Ｍｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ｌｉｍｉｔｅｄ 高脂肪食関連疾患を阻害する方法
JP7091958B2 (ja) * 2018-09-11 2022-06-28 株式会社デンソー 射出成形品の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825840A1 (de) * 1988-07-29 1990-02-01 Basf Ag Dihydrodibenzofuranderivate und diese verbindungen enthaltende fungizide
KR20040072697A (ko) * 2001-12-31 2004-08-18 액테리온 파마슈티칼 리미티드 피롤리돈 카르복사미드

Also Published As

Publication number Publication date
TW200740786A (en) 2007-11-01
JP4085129B2 (ja) 2008-05-14
WO2007018193A1 (ja) 2007-02-15
AU2006277289A1 (en) 2007-02-15
EP1914229A1 (en) 2008-04-23
DE602006014973D1 (de) 2010-07-29
RU2008108997A (ru) 2009-09-20
JPWO2007018193A1 (ja) 2009-02-19
IL189172A0 (en) 2008-06-05
EP1914229B1 (en) 2010-06-16
EP1914229A4 (en) 2009-03-18
KR20080033367A (ko) 2008-04-16
US20090036492A1 (en) 2009-02-05
CA2618622A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
NO20081220L (no) Nytt cercosporamidderivat
ATE388146T1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
TW200833675A (en) Nicotinamide derivatives
NO20076498L (no) Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
NO20084338L (no) Neurogenesis fremkaller eller terapeutisk neuropatimiddel omfattende alkyl eter derivater eller salter derav
NO20084127L (no) Benzylfenylglukopyranosidderivat
NO20076524L (no) Pyrazolforbindelse samt terapeutisk middel for diabetes som omfatter det samme
MY142807A (en) Benzimidazole derivative and use thereof.
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20076196L (no) Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
NO20063446L (no) Tiazolderivater
NO20091599L (no) Kjemiske forbindelser
WO2008078196A3 (en) Substituted heteroaryl pyridopyrimidone derivatives
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20091596L (no) Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
NO20075409L (no) Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater
NO20091301L (no) Nye aminopyridinderivater med aurora A selektiv inhiberende aktivitet
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
NO20075617L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application